Comment on "Chronic spontaneous urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab".

Abdelmaksoud, Ayman; Goldust, Mohamad; Vestita, Michelangelo

Abdelmaksoud, Ayman; Goldust, Mohamad; Vestita, Michelangelo.

Abdelmaksoud A; Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.
Goldust M; Department of Dermatology, University of Rome G. Marconi, Rome, Italy.
Vestita M; Department of Dermatology, University Medical Center Mainz, Mainz, Germany.

Int J Dermatol ; 59(11): 1417-1418, 2020 11.

Article in English | MEDLINE | ID: covidwho-800437

Subject(s)

Anti-Allergic Agents; COVID-19; Chronic Urticaria; Urticaria; Anti-Allergic Agents/therapeutic use; Humans; Omalizumab/therapeutic use; SARS-CoV-2; Urticaria/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Urticaria / Anti-Allergic Agents / Chronic Urticaria / COVID-19 Limits: Humans Language: English Journal: Int J Dermatol Year: 2020 Document Type: Article Affiliation country: Ijd.15215

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google